Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

487
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
487
An Overview of Psychoactive Drugs01:28

An Overview of Psychoactive Drugs

474
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
474
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

413
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
413
Stimulants01:29

Stimulants

751
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
751
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

669
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
669
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

1.0K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Schools Responding to the Special Needs of Girls.

Child and adolescent psychiatric clinics of North America·2025
Same author

Correction: Mortality following adolescent substance treatment: 21-year follow-up from a single clinical site.

Frontiers in child and adolescent psychiatry·2025
Same author

A learning health system model for addressing substance use: Denver Health Center for Addiction Medicine.

Learning health systems·2025
Same author

Mortality following adolescent substance treatment: 21-year follow-up from a single clinical site.

Frontiers in child and adolescent psychiatry·2025
Same author

Changes in psychosis-related emergency department and hospitalization rates among youth following cannabis legalization in Colorado.

Drug and alcohol dependence·2025
Same author

Antecedents and Trajectories of the Child and Adolescent Mental Health Crisis: Assimilating Empirically Guided Pathways for Stakeholders.

The primary care companion for CNS disorders·2024
Same journal

Severe Postoperative Hypernatremia in an Adolescent Following Sleeve Gastrectomy.

Pediatrics·2026
Same journal

Barriers to Implementing SMART for Asthma in Pediatric Primary Care.

Pediatrics·2026
Same journal

Blood Lead Testing Among Children Enrolled in Medicaid.

Pediatrics·2026
Same journal

From Screening to Support: Crafting Social Needs Response Systems That Work for Families.

Pediatrics·2026
Same journal

A Social Care Intervention in Pediatric Practices: A Stepped Wedge Cluster Trial.

Pediatrics·2026
Same journal

Pediatric Cheerleading-Related Head Injuries and the "Double Down" Rule Change.

Pediatrics·2026
See all related articles

Related Experiment Video

Updated: Dec 22, 2025

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

695

Marijuana Legalization and Youth.

Kristie Ladegard1,2, Christian Thurstone1,2, Melanie Rylander3,2,4

  • 1Departments of Psychiatry and.

Pediatrics
|May 3, 2020
PubMed
Summary
This summary is machine-generated.

Marijuana legalization is linked to increased adolescent use and potential harm. Pediatricians must address rising youth marijuana use and its mental health and cognitive impacts.

More Related Videos

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

531
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.3K

Related Experiment Videos

Last Updated: Dec 22, 2025

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

695
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

531
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.3K

Area of Science:

  • Public Health
  • Adolescent Medicine
  • Cannabis Research

Background:

  • Increasing legalization of marijuana for medical and recreational use.
  • Concurrent rise in adolescent marijuana use and decreased perception of harm.
  • Significant concern regarding adolescent marijuana exposure's potential negative impacts.

Purpose of the Study:

  • Analyze current data on marijuana legalization's effect on adolescent use.
  • Examine the impact of adolescent marijuana use on mental health and cognition.
  • Review interventions for pediatric settings to address these challenges.

Main Methods:

  • Systematic review of recent studies on marijuana legalization and adolescent use.
  • Analysis of data linking adolescent cannabis exposure to mental health outcomes.
  • Evaluation of current pediatric intervention strategies for marijuana use.

Main Results:

  • Legalization correlates with increased adolescent marijuana consumption.
  • Adolescent use is associated with adverse mental health outcomes, including psychosis and addiction.
  • Cognitive deficits and academic performance declines are observed in adolescent users.

Conclusions:

  • Pediatricians play a crucial role in educating families about marijuana legalization's risks.
  • Proactive pediatric interventions are necessary to mitigate negative impacts on youth.
  • Continued research and updated guidance are essential for addressing evolving cannabis policies.